JPS6141553B2 - - Google Patents
Info
- Publication number
- JPS6141553B2 JPS6141553B2 JP16410179A JP16410179A JPS6141553B2 JP S6141553 B2 JPS6141553 B2 JP S6141553B2 JP 16410179 A JP16410179 A JP 16410179A JP 16410179 A JP16410179 A JP 16410179A JP S6141553 B2 JPS6141553 B2 JP S6141553B2
- Authority
- JP
- Japan
- Prior art keywords
- serine
- glycine
- medium
- growth
- resistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 28
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 24
- 229960001153 serine Drugs 0.000 claims description 16
- 241000589516 Pseudomonas Species 0.000 claims description 14
- 239000004471 Glycine Substances 0.000 claims description 12
- VDBCTDQYMZSQFQ-UHFFFAOYSA-N glycine hydroxamate Chemical compound NCC(=O)NO VDBCTDQYMZSQFQ-UHFFFAOYSA-N 0.000 claims description 10
- SGCJRDDJGFXEAB-VKHMYHEASA-N (2s)-2-[(2-chloroacetyl)amino]-3-hydroxypropanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)CCl SGCJRDDJGFXEAB-VKHMYHEASA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- -1 carbobenzyloxyserine Chemical compound 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 239000002609 medium Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930195711 D-Serine Natural products 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- GNIDSOFZAKMQAO-VIFPVBQESA-N (2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 GNIDSOFZAKMQAO-VIFPVBQESA-N 0.000 description 2
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- XLOUELBZSKNZSP-VIFPVBQESA-N (2s)-3-hydroxy-2-(phenylmethoxyamino)propanoic acid Chemical compound OC[C@@H](C(O)=O)NOCC1=CC=CC=C1 XLOUELBZSKNZSP-VIFPVBQESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 1
- 108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 1
- 108010059247 Hydroxypyruvate reductase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940021746 d- serine Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
Description
本発明は発酵法によるL−セリンの製造方法に
関するものである。
さらに詳しくはシユードモナス属に属したグリ
シンからL−セリンを生産する能力を有し、かつ
クロロアセチルセリンまたはカーボベンゾオキシ
セリンまたはグリシンヒドロキサメートに耐性を
有する変異株を、グリシンを含有する栄養培地中
に培養し、培地中に生成蓄積したL−セリンを採
取することを特徴とする発酵法によるL−セリン
の製造方法である。
発酵法によるL−セリンの製造方法としては、
コリネバクテリウム属やシユードモナス属等の微
生物により、グリシンより製造する方法が知られ
ている。
本発明者等は、L−セリンの製造方法について
鋭意研究を重ねた結果、シユードモナス属に属し
クロロアセチルセリン、カーボベンジルオキシセ
リン、グリシンヒドロキサメートに抵抗性を有す
る変異株の多くが、グリシンより高い収率でL−
セリンを生成蓄積する事実を見出した。
本発明において用いる微生物は、シユードモナ
ス属に属しクロロアセチルセリン、カーボベンジ
ルオキシセリン、グリシンヒドロキサメートに耐
性を有する変異株である。耐性を有する変異株と
は、親株にくらべこれらの薬剤に対し生育阻害の
程度が低下したような株をいう。これらの変異株
を採取するには、公知の変異処理法である紫外
線、薬剤処理、γ−線照射などの変異処理を親株
に施した後、親株に生育できないような量のクロ
ロアセチルセリン、カーボベンジルオキシセリ
ン、グリシンヒドロキサメート等を含有する寒天
培地または液体培地に生育できる菌株を選択すれ
ばよい。本発明に使用する変異株として具体的に
はシユードモナス ロドメチロフアシエンス
AJ 11503FERM−P5308(カーボベンジルオキシ
セリン耐性)、シユードモナス ロドメチロフア
シエンスAJ 11504 FERM−P5309(クロロアセ
チルセリン耐性)、シユードモナス ロドメチロ
フアシエンス AJ 11505 FERM−P5310(D−
セリン耐性、グリシンヒドロキサメート耐性)、
シユードモナス ロドメチロフアシエンス AJ
11506 FERM−P5311(グリシンヒドロキサメー
ト耐性)をあげることができる。これらの変異株
はシユードモナス ロドメチロフアシエンス
AJ 11261、FERM−P4531を親株としてさらに変
異誘導して得られたものである。親株AJ 11261
からの変異誘導方法は次の通りである。
メタノール2ml/dlを含有する肉汁液体培地で
30℃、24時間培養したシユードモナス ロドメチ
ロフアシエンス AJ 11261の菌体をニトロソグ
アニジン250μg/mlを含む50mMリン酸バツフア
ー(PH7.0)10mlに懸濁し、この懸濁液を30℃、
15分間振盪する。振盪後菌体を洗浄して適当に稀
釈し、D−セリン、クロロアセチルセリンあるい
はカーボベンゾキシセリン、またはグリシンヒド
ロキサメートを0.1〜10mg/ml添加した。メタノー
ル1.5ml/dl含有の最少生育培地、KH2PO40.06
%、(NH4)2HPO40.2%、MgSO4・7H2O0.02%、
NaCl 0.05%、FeSO4・7H2O0.001%、MnSO4・
nH2O0.0005%に菌体を接種し、30℃で7〜15日
間培養した培養液を、メタノール2ml/dl含有ブ
イヨン寒天平板培地に塗布し、30℃で2〜4日間
培養して生育してきたコロニーの中からL−セリ
ン生産性の優れたものを採取した。
なおこれらの変異株の具体的な採取方法は、最
少生育培地KH2PO40.06%、(NH4)2HPO40.2%、
MgSO4・7H2O0.02%、NaCl 0.05%、FeSO4・
7H2O0.001%、MnSO4・nH2O0.0005%、メタノ
ール1.5%の組成の倍地5mlを試験管に入れ、さ
らにD−セリン、クロロアセチルセリン、カーボ
ベンゾオキシセリン、グリシンヒドロキサメート
等の薬剤を0〜1000mg/dlになるように各々試験
管に入れた。これらの各薬剤の入つた試験管に、
メタノール2%含有肉汁スラントで30℃48時間培
養した親株AJ 11261を50mMリン酸バツフアー
(PH7.0)10mlに懸濁し、その懸濁液を0.1ml接植
し30℃、2〜4日間振盪培養を行つた。各濃度の
薬剤の入つた培養終了液の菌増殖度を波長562n
mで測定することにより、各薬剤に対する生育阻
止濃度を知ることができた。したがつて耐性変異
株の採取は、ニトロソグアニジンによる変異処理
後の親株を各薬剤(D−セリン、クロロアセチル
セリン、カーボベンゾキシセリン、グリシンヒド
ロキサメート)の生育阻止濃度以上添加された最
少生育培地に接種し、30℃、7〜15日間培養し、
生育してきた耐性変異株をメタノール2%含有肉
汁プレートに撤き生育してきたコロニーを分離し
た。
各薬剤に対する生育阻止濃度及び抵抗性変異株
採集濃度を第1表に示す。
The present invention relates to a method for producing L-serine using a fermentation method. More specifically, a mutant strain belonging to the genus Pseudomonas that has the ability to produce L-serine from glycine and is resistant to chloroacetylserine, carbobenzooxyserine, or glycine hydroxamate is grown in a nutrient medium containing glycine. This is a method for producing L-serine using a fermentation method, which is characterized by culturing L-serine in a culture medium and collecting L-serine produced and accumulated in a medium. As a method for producing L-serine by fermentation method,
A method of producing glycine using microorganisms such as Corynebacterium and Pseudomonas is known. As a result of extensive research into the production method of L-serine, the present inventors found that many mutant strains belonging to the genus Pseudomonas that are resistant to chloroacetylserine, carbobenzyloxyserine, and glycine hydroxamate are more resistant to glycine than glycine. L- in high yield
We discovered the fact that serine is produced and accumulated. The microorganism used in the present invention is a mutant strain belonging to the genus Pseudomonas that is resistant to chloroacetylserine, carbobenzyloxyserine, and glycine hydroxamate. A resistant mutant strain refers to a strain that exhibits a reduced degree of growth inhibition against these drugs compared to the parent strain. To collect these mutant strains, the parent strain is subjected to known mutation treatment methods such as ultraviolet rays, drug treatment, and γ-ray irradiation. A strain that can grow on an agar medium or liquid medium containing benzyloxyserine, glycine hydroxamate, etc. may be selected. Specifically, the mutant strain used in the present invention is Pseudomonas rhodomethylofaciens.
AJ 11503FERM-P5308 (carbobenzyloxyserine resistant), Pseudomonas rhodomethylofaciens AJ 11504 FERM-P5309 (chloroacetylserine resistant), Pseudomonas rhodomethylofaciens AJ 11505 FERM-P5310 (D-
serine resistance, glycine hydroxamate resistance),
Pseudomonas rhodomethylofaciens AJ
11506 FERM-P5311 (glycine hydroxamate resistant). These mutant strains are Pseudomonas rhodomethylofaciens
This strain was obtained by further mutating AJ 11261 and FERM-P4531 as parent strains. Parent stock AJ 11261
The method for inducing mutations from is as follows. In broth liquid medium containing 2 ml/dl of methanol.
Pseudomonas rhodomethylofaciens AJ 11261 cells cultured at 30°C for 24 hours were suspended in 10ml of 50mM phosphate buffer (PH7.0) containing 250μg/ml of nitrosoguanidine, and this suspension was incubated at 30°C for 24 hours.
Shake for 15 minutes. After shaking, the bacterial cells were washed and diluted appropriately, and 0.1 to 10 mg/ml of D-serine, chloroacetylserine, carbobenzoxyserine, or glycine hydroxamate was added. Minimal growth medium containing methanol 1.5ml/dl, KH 2 PO 4 0.06
%, (NH 4 ) 2 HPO 4 0.2%, MgSO 4 7H 2 O 0.02%,
NaCl 0.05%, FeSO4・7H2O0.001 %, MnSO4・
Bacterial cells were inoculated in 0.0005% nH 2 O and cultured at 30°C for 7 to 15 days. The culture solution was applied to a bouillon agar plate containing 2 ml/dl of methanol and cultured at 30°C for 2 to 4 days to grow. Among the colonies, those with excellent L-serine productivity were collected. The specific method for collecting these mutant strains is as follows: minimum growth medium KH 2 PO 4 0.06%, (NH 4 ) 2 HPO 4 0.2%,
MgSO4・7H2O0.02 %, NaCl 0.05%, FeSO4・
Put 5 ml of a medium with a composition of 0.001% 7H 2 O, 0.0005% MnSO 4 nH 2 O, and 1.5% methanol into a test tube, and add D-serine, chloroacetylserine, carbobenzooxyserine, and glycine hydroxamate. Each drug was added to a test tube at a concentration of 0 to 1000 mg/dl. In test tubes containing each of these drugs,
The parent strain AJ 11261, which was cultured for 48 hours at 30°C in a broth slant containing 2% methanol, was suspended in 10ml of 50mM phosphate buffer (PH7.0), and 0.1ml of the suspension was inoculated and cultured with shaking at 30°C for 2 to 4 days. I went to The bacterial growth rate of the cultured solution containing each concentration of drug was measured at a wavelength of 562n.
By measuring in m, it was possible to know the growth-inhibiting concentration for each drug. Therefore, to collect resistant mutant strains, the parent strain after mutation treatment with nitrosoguanidine is treated with the minimum growth inhibitory concentration of each drug (D-serine, chloroacetylserine, carbobenzoxyserine, glycine hydroxamate) added to the growth-inhibiting concentration. Inoculated into a medium and cultured at 30°C for 7 to 15 days.
The resistant mutant strain that had grown was removed to a broth plate containing 2% methanol, and the growing colonies were isolated. Table 1 shows the growth-inhibiting concentrations and concentrations of resistant mutants collected for each drug.
【表】
なおシユードモナス ロドメチロフアシエンス
(Pseudomonas rhodomethylofaciens)AJ 11261
FERM−P4531は新菌種に分類されたものであ
り、その菌学的性質は以下の通りである。
(a) 形 態
(1) 細胞の形および大きさ:
大型の桿菌、1.0〜1.5×2〜5ミクロン
(2) 細胞の多形性の有無:
あり、ポリβ−ハイドロオキシ酪酸の顆粒を
菌体内に形成
(3) 運動性の有無 鞭毛の着生状態:有り 極
鞭毛
(4) 胞子の有無、形状、大きさ、部位:なし
(5) グラム染色性:陰性
(6) 抗酸性:陰性
(b) 各培地における生育状態
(1) 肉汁寒天平板培養:中等の生育、円形、全
縁、
半レンズ状、約質、黄橙色、不透明
(2) 肉汁寒天斜面培養:中等の生育、糸状、赤
橙色、
不透明、水溶性色素は生成しない
(3) 肉汁液体培養:中等の生育、リング状
(4) 肉汁ゼラチン穿刺培養:
上部に生育、好気的 液化しない
(5) リトマス・ミルク:変化なし
(c) 生理学的性質
(1) 硝酸塩の還元:陽性
(2) 脱窒反応:陰性
(3) MRテスト:陰性
(4) VPテスト:陰性
(5) インドールの生成:陰性
(6) 硫化水素の生成:陰性
(7) デンプンの加水分解:陰性
(8) クエン酸の利用:
Koser培地 微弱に利用する
Christensen培地微弱に利用する
(9) 無機窒素源の利用:(メタノール培地)
硝酸塩 利用する
アンモニウム 利用する
(10) 色素の生成:生成せず
(11) ウレアーゼ:陰性
(12) オキシダーゼ:陽性
(13) カタラーゼ:陽性
(14) 生育の範囲
温度 10〜38℃ 41℃では生育できない
PH 6〜8
(15) 酸素に対する態度:好気性[Table] Pseudomonas rhodomethylofaciens AJ 11261
FERM-P4531 is classified as a new bacterial species, and its mycological properties are as follows. (a) Morphology (1) Cell shape and size: Large rod, 1.0-1.5 x 2-5 microns (2) Presence or absence of cell pleomorphism: Yes, poly-β-hydroxybutyric acid granules Formed in the body (3) Motile status Flagellum epiphytic status: Yes Polar flagella (4) Spore presence, shape, size, and location: None (5) Gram staining: Negative (6) Acid-fast: Negative ( b) Growth status in each culture medium (1) Broth agar plate culture: Moderate growth, circular, whole-rimmed, semi-lenticular, sparse, yellow-orange, opaque (2) Broth agar slant culture: Moderate growth, filamentous, red Orange, opaque, no water-soluble pigments (3) Meat juice liquid culture: moderate growth, ring-shaped (4) Meat juice gelatin puncture culture: growth on top, aerobic, no liquefaction (5) Litmus milk: no change ( c) Physiological properties (1) Nitrate reduction: Positive (2) Denitrification reaction: Negative (3) MR test: Negative (4) VP test: Negative (5) Indole production: Negative (6) Hydrogen sulfide production : Negative (7) Hydrolysis of starch: Negative (8) Use of citric acid: Koser medium Use slightly Christensen medium Use slightly (9) Use of inorganic nitrogen sources: (Methanol medium) Nitrate Use ammonium Use (10) Pigment production: No production (11) Urease: Negative (12) Oxidase: Positive (13) Catalase: Positive (14) Growth range temperature 10-38℃ Cannot grow at 41℃ PH 6-8 (15 ) Attitude towards oxygen: aerobic
【表】【table】
【表】 (17) ポリ−β−ヒドロキシ酪酸の蓄積:+ (18) 栄養要求性:なし【table】 (17) Accumulation of poly-β-hydroxybutyric acid: + (18) Auxotrophy: None
【表】【table】
【表】
(20) その他の性質
L−セリンヒドロオキシメチルトランスフエ
ラーゼ活性:陽性
ヒドロオキシピルビン酸レダクターゼ活性:
陽性
本菌種は上記の如く、グラム陰性の桿菌で極単
鞭毛を有しており運動性があり好気的である。ま
た糖より酸を生成する性質があり、バージエイズ
マニユアル第8版によるとシユードモナス属に属
する。また栄養要求性がないこと、菌体内にポリ
−β−ハイドロオキシ酪酸を蓄積すること、アル
ギニンの資化性がないこと、赤色の色素を有する
等の特徴で既知の菌種とは異なる新菌種と判断し
シユードモナス ロドメチロフアシエンスと命名
した。
本発明の上記変異株を培養する倍地は、グリシ
ンの他に炭素源、窒素源、無機イオン、ビタミ
ン、アミノ酸等の有機微量栄養素を含有するもの
であれば合成培地、天然培地のいずれでも使用す
ることができる。グリシンは倍地に予め添加して
おいてもよく、あるいは培養途中に添加してもよ
い。又変異株の生育の阻害が軽減するよう培地中
のグリシン濃度が低くなるよう少量づつ分割添加
してもよい。
炭素源としてはメタノールが最適であるが、適
当な菌株を選択すればエタノール、プロパノール
等のアルコール類、蟻酸、酢酸等の有機酸類、グ
ルコース等の炭水化物も使用できるものがある。
窒素源としてはアンモニア水、アンモニウム
塩、硝酸塩、アミノ酸その他の通常用いられてい
るいずれの窒素源も使用できる。
無機イオンとしてはカリ、マグネシウム、鉄、
マンガン、カルシウム、クロール、硫酸、リン酸
等のイオンを必要に応じ使用する。
さらに有機微量栄養素としてビタミン類、アミ
ノ酸類、コーンステイーブリカー、酵母エキス、
肉エキス、大豆蛋白加水分解物等を添加してもよ
い。
培養は好気的条件で行うのがよく、PHは通常5
〜9の範囲で好ましくは中性附近がよい。培養温
度は25〜37℃の範囲で培養するのが望ましい。培
地のPH調整はCaCO3、酸、アルカリ溶液、アン
モニアガス等によつて行う。培養を好気条件下で
2〜8日間行うことにより、発酵終了液中に著量
のL−セリンが蓄積される。培養終了液よりL−
セリンを回収するには、イオン交換樹脂法を用い
る方法等一般に知られている通常の回収方法によ
つて行なうことができる。
以下、本発明を実施例により具体的に説明す
る。
実施例 1
KH2PO40.05%、(NH4)2SO40.5%、MgSO4・
7H2O0.04%、NCl 0.05%、FeSO4・7H2O0.001
%、MnSO4・nH2O0.0005%、酵母エキス0.2%、
メタノール1.5%(別殺菌)、CaCO35%、(PH
7.0)の組成の培地20mlを500ml容坂口フラスコに
入れ殺菌した。これにメタノール2%含有肉汁ス
ラントで30℃、48時間培養した第1表に示す菌株
を各々1白金耳接種し、31.5℃で振盪培養を行な
つた。培養24時間後にメタノール1.5%を添加
し、さらに24時間培養してからグリシン1.5%、
メタノール4%を添加し、その後さらに48時間培
養を行なつた。L−セリンの生成量は第2表に示
すとうりであつた。[Table] (20) Other properties L-serine hydroxymethyltransferase activity: Positive Hydroxypyruvate reductase activity:
Positive As mentioned above, this bacterial species is a Gram-negative bacillus, has a polar monoflagellate, is motile, and is aerobic. It also has the property of producing acids rather than sugars, and according to the 8th edition of Barge's Manual, it belongs to the genus Pseudomonas. In addition, new bacteria differ from known bacterial species due to characteristics such as lack of auxotrophy, accumulation of poly-β-hydroxybutyric acid within the bacterial body, lack of ability to assimilate arginine, and red pigmentation. It was determined to be a species and was named Pseudomonas rhodomethylofaciens. The medium for culturing the mutant strain of the present invention may be either a synthetic medium or a natural medium as long as it contains organic micronutrients such as carbon sources, nitrogen sources, inorganic ions, vitamins, and amino acids in addition to glycine. can do. Glycine may be added to the medium in advance or during the culture. Alternatively, the glycine may be added in small portions so that the concentration of glycine in the medium is lowered to reduce inhibition of growth of the mutant strain. Methanol is most suitable as a carbon source, but alcohols such as ethanol and propanol, organic acids such as formic acid and acetic acid, and carbohydrates such as glucose can also be used if an appropriate strain is selected. As the nitrogen source, aqueous ammonia, ammonium salts, nitrates, amino acids, and any other commonly used nitrogen sources can be used. Inorganic ions include potassium, magnesium, iron,
Ions such as manganese, calcium, chloride, sulfuric acid, and phosphoric acid are used as necessary. In addition, organic micronutrients such as vitamins, amino acids, corn staple liquor, yeast extract,
Meat extract, soybean protein hydrolyzate, etc. may be added. Cultivation is best carried out under aerobic conditions, with a pH of usually 5.
-9, preferably around neutrality. It is desirable to culture at a temperature in the range of 25 to 37°C. The pH of the medium is adjusted using CaCO 3 , acid, alkaline solution, ammonia gas, etc. By culturing under aerobic conditions for 2 to 8 days, a significant amount of L-serine is accumulated in the fermented liquid. L- from the culture finished solution
Serine can be recovered by commonly known recovery methods such as a method using an ion exchange resin method. Hereinafter, the present invention will be specifically explained with reference to Examples. Example 1 KH 2 PO 4 0.05%, (NH 4 ) 2 SO 4 0.5%, MgSO 4 .
7H2O0.04 %, NCl 0.05%, FeSO4・7H2O0.001
%, MnSO4・nH2O0.0005 %, yeast extract 0.2%,
Methanol 1.5% (separate sterilization), CaCO3 5%, (PH
7.0) was placed in a 500 ml Sakaguchi flask and sterilized. One platinum loopful of each of the strains shown in Table 1, which had been cultured in a broth slant containing 2% methanol at 30°C for 48 hours, was inoculated into each strain, and cultured with shaking at 31.5°C. After 24 hours of culture, 1.5% methanol was added, and after 24 hours of culture, 1.5% glycine was added.
4% methanol was added, followed by further culturing for 48 hours. The amount of L-serine produced was as shown in Table 2.
【表】【table】
【表】【table】
Claims (1)
セリンを生産する能力を有し、かつクロロアセチ
ルセリン、又はカーボベンジルオキシセリン又は
グリシンヒドロキサメートに耐性を有する変異株
を、グリシンを含有する培地中に培養し、培養液
中に生成蓄積したL−セリンを採取することを特
徴とするL−セリンの製造方法。1 Belongs to the genus Pseudomonas, and from glycine to L-
A mutant strain that has the ability to produce serine and is resistant to chloroacetylserine, carbobenzyloxyserine, or glycine hydroxamate was cultured in a medium containing glycine, and L was produced and accumulated in the culture solution. - A method for producing L-serine, which comprises collecting serine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16410179A JPS5688798A (en) | 1979-12-19 | 1979-12-19 | Preparation of l-serine by fermentation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16410179A JPS5688798A (en) | 1979-12-19 | 1979-12-19 | Preparation of l-serine by fermentation method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5688798A JPS5688798A (en) | 1981-07-18 |
JPS6141553B2 true JPS6141553B2 (en) | 1986-09-16 |
Family
ID=15786775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16410179A Granted JPS5688798A (en) | 1979-12-19 | 1979-12-19 | Preparation of l-serine by fermentation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5688798A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4528273A (en) * | 1983-11-22 | 1985-07-09 | W. R. Grace & Co. | Microorganism strains for the fermentative preparation of L-serine |
-
1979
- 1979-12-19 JP JP16410179A patent/JPS5688798A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5688798A (en) | 1981-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4529697A (en) | Process for producing L-glutamic acid by fermentation | |
US4542098A (en) | Production of glucose dehydrogenase and use of the resultant enzyme in the enzymatic synthesis of L-carnitine | |
JPS6129718B2 (en) | ||
US3943038A (en) | Method for producing amino acids by culturing hydrogen-oxidizing bacteria | |
NZ225225A (en) | Acid urease and its microbial production | |
JPH04365491A (en) | Production of 4-halo-3-hydroxybutylamide | |
JPH08187092A (en) | Improving method of hydration activity for converting nitryl compound contained in thermophilic microorganism to amide compound | |
JP3525190B2 (en) | Strain producing ε-poly-L-lysine in remarkable quantity and method for producing ε-poly-L-lysine using the same | |
JPS6141553B2 (en) | ||
US5130240A (en) | Process for producing d-alpha-alanine and/or l-alpha-alanineamide by arthrobacter sp | |
JPS6117465B2 (en) | ||
US3905866A (en) | Process for production of L-lysine by fermentation | |
US3144395A (en) | Process for preparing 6-aminopenicillanic acid by bacillus megaterium | |
US5258305A (en) | Manufacture of optically active 2-phenylpropionic acid and 2-phenylpropionamide from the nitrile using Rhodococcus equi | |
US5252470A (en) | D-amidase and process for producing D-α-alanine and/or L-α-alanineamide | |
US4271267A (en) | Preparation of L-trytophan by fermentation | |
JP3122990B2 (en) | Process for producing O-methyl-L-tyrosine and L-3- (1-naphthyl) alanine | |
US5496715A (en) | Process for preparing indigo | |
JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
US3920520A (en) | Fermentation process for producing optically active L-lysine | |
JPS6117474B2 (en) | ||
JPS641115B2 (en) | ||
Hong et al. | A 3, 5-diaminohexanoate-decomposing Brevibacterium | |
JP3873512B2 (en) | Method for producing D-3- (2-naphthyl) alanine | |
JPH025398B2 (en) |